Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.

Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M.

J Biol Chem. 1998 Jun 26;273(26):16501-8.

2.

Gene regulation in melanoma progression by the AP-2 transcription factor.

Bar-Eli M.

Pigment Cell Res. 2001 Apr;14(2):78-85. Review.

PMID:
11310795
3.

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M.

EMBO J. 1998 Aug 3;17(15):4358-69.

4.

Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.

Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M.

Cancer Res. 1997 Jun 1;57(11):2295-303.

5.

Role of AP-2 in tumor growth and metastasis of human melanoma.

Bar-Eli M.

Cancer Metastasis Rev. 1999;18(3):377-85. Review.

PMID:
10721491
7.

Molecular mechanisms of melanoma metastasis.

Bar-Eli M.

J Cell Physiol. 1997 Nov;173(2):275-8.

PMID:
9365536
8.

Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.

Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M.

Oncogene. 1997 Oct 23;15(17):2069-75.

9.

Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.

Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M.

Cancer Res. 2002 Sep 1;62(17):5106-14.

10.

Molecular changes in human melanoma metastasis.

Luca MR, Bar-Eli M.

Histol Histopathol. 1998 Oct;13(4):1225-31. Review.

PMID:
9810513
11.

MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.

Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Faé I, Waclavicek M, Stöckl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W.

J Immunol. 1997 Mar 1;158(5):2107-15.

PMID:
9036955
12.

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.

Clin Cancer Res. 2005 Jan 1;11(1):267-72.

13.

Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.

Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.

Oncogene. 2001 Jun 7;20(26):3363-75.

14.
15.

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.

Gene. 2001 Nov 14;279(1):17-31.

PMID:
11722842
16.

Transcriptional regulation of metastasis-related genes in human melanoma.

Nyormoi O, Bar-Eli M.

Clin Exp Metastasis. 2003;20(3):251-63. Review.

PMID:
12741683
17.

Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.

Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M.

Melanoma Res. 1993 Feb;3(1):35-41.

PMID:
8471835
18.

Role and regulation of the thrombin receptor (PAR-1) in human melanoma.

Tellez C, Bar-Eli M.

Oncogene. 2003 May 19;22(20):3130-7. Review.

PMID:
12789289
19.
20.

Regulation of gene expression in melanoma: new approaches for treatment.

Leslie MC, Bar-Eli M.

J Cell Biochem. 2005 Jan 1;94(1):25-38.

PMID:
15523674
Items per page

Supplemental Content

Write to the Help Desk